Cargando…
Cell Cycle Progression or Translation Control Is Not Essential for Vesicular Stomatitis Virus Oncolysis of Hepatocellular Carcinoma
The intrinsic oncolytic specificity of vesicular stomatitis virus (VSV) is currently being exploited to develop alternative therapeutic strategies for hepatocellular carcinoma (HCC). Identifying key regulators in diverse transduction pathways that define VSV oncolysis in cancer cells represents a fu...
Autores principales: | Marozin, Sabrina, De Toni, Enrico N., Rizzani, Antonia, Altomonte, Jennifer, Junger, Alexandra, Schneider, Günter, Thasler, Wolfgang E., Kato, Nobuyuki, Schmid, Roland M., Ebert, Oliver |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881869/ https://www.ncbi.nlm.nih.gov/pubmed/20539760 http://dx.doi.org/10.1371/journal.pone.0010988 |
Ejemplares similares
-
Activation of Nrf2 Signaling Augments Vesicular Stomatitis Virus Oncolysis via Autophagy-Driven Suppression of Antiviral Immunity
por: Olagnier, David, et al.
Publicado: (2017) -
Mechanisms that allow vaccination against an oncolytic vesicular stomatitis virus-encoded transgene to enhance safety without abrogating oncolysis
por: AuYeung, Amanda W. K., et al.
Publicado: (2021) -
Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy: Defeating Cancer with a “Hammer” and “Anvil”
por: Melzer, Michael Karl, et al.
Publicado: (2017) -
Aphthæ, or Vesicular Stomatitis of the Horse
por: Hutcheon, D.
Publicado: (1898) -
The synthetic futures of vesicular stomatitis virus
por: Overend, Christopher, et al.
Publicado: (2012)